🔗 Share this article

Given that the US undertakes unprecedented revisions to its vaccine guidelines, an unexpected name has emerged unexpectedly: Dr. Tracy Beth Høeg, a Danish American sports physician and epidemiologist who rose to prominence by questioning Covid shots during the global health crisis and has zeroed in on possible deaths after Covid immunization in her brief tenure at the FDA.

Planned Changes to Childhood Immunization Program

Health officials were set to unveil radical revisions to the childhood immunization program recently, bringing the US with the Danish immunization schedule, according to reports – a major change that would put the US out of alignment with much of the international standard with no evidence for improved outcomes. The planned update has been pushed back until the next year.

Instead of the director of the vaccine center, Dr. Høeg is set to address the audience at the meeting. She was newly appointed acting director of the FDA’s CDER, the fifth person to head the center this calendar year.

Consolidating Power at the Agency

Høeg's temporary position might represent a tighter collaboration between the pharmaceutical and vaccine branches as Høeg and Prasad solidify control at the regulatory agency – and it signals a renewed priority upon rolling back previously authorized immunizations at the FDA.

Høeg has often pushed for ending some pediatric immunization guidelines in the US to become more in line with Denmark's approach, a country with comprehensive healthcare and a population roughly the size of Wisconsin’s.

In her initial statements, she has kept her attention on vaccines – usually the purview of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Doubts Over Expertise

The appointee has no obvious background in drug development, regulation or leadership, which has been customary for previous directors of the biologics center. She has served at the FDA as a senior adviser to the commissioner and the vaccine center since spring.

“She appears not to have any of the qualifications” for overseeing the CDER, remarked a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in running a major agency. She is not an expert in industry regulation.”

Past commissioners of the center would “grasp legal statutes and the science of drug development”, commented Janet Woodcock. “Frankly, she doesn’t have the kind of background that former directors who led the center have had.”

CDER has an immense range of responsibilities at the FDA, she pointed out.

“Everybody just zeroes in on the new drug program, but the off-patent medication office clears a multitude of generic drugs. There is also a biosimilars program, over-the-counter program and more, and each of these must be managed,” she noted. “The area you overlook, that is precisely what that I always told people is going to bite you.”

Additionally, a substantial administrative aspect to the role, which supervises more than 5,000 personnel. “It is a massive management job, if you do it right,” she said.

Official Statement and Controversial Initiatives

In response to questions about Dr. Høeg's qualifications and whether this assignment signifies increased cooperation among FDA leaders on immunizations, a press secretary said that the “inquiries stem from flawed assumptions”.

“This background matches the responsibilities of her job,” the spokesperson explained, citing the period Dr. Høeg spent counseling the FDA commissioner on “medication safety and approval science, including predictive safety algorithms and immunization monitoring”.

As acting director, Høeg inherits the commissioner’s new fast-track approval initiative, a controversial expedited drug-approval program that reportedly concerned her predecessors. “By what process are these therapies being chosen for this voucher program? Who makes the calls?” Howard questioned. “There’s a lot of confidentiality occurring at the agency right now.”

Overall, he remarked, “the Food and Drug Administration seems to be moving towards less stringent regulations of pharmaceuticals, except for shots.”

Documented History on Vaccines

Concerning vaccines, Dr. Høeg has a more documented, if troubling, track record, some experts said. She authored a analysis using non-validated crowd-sourced reports to determine the rate of heart inflammation after Covid immunization. She advised the state of Florida surgeon general Joseph Ladapo, who was said to have changed statistics to imply Covid vaccinations are pose a greater threat than they are.

Part of her “desired changes” for the incoming federal leadership encompassed altering rules for novel immunizations and ending “unnecessary” immunizations, she stated following the vote on a podcast. At the FDA, Dr. Høeg has according to sources suggested excluding young men from obtaining Covid vaccinations.

“She is an complete dogmatist who starts off with her preconceived notions and reverse-engineers to retrofit the evidence in a very disingenuous, untruthful manner,” Howard stated.

Gaining Influence and a “Campaign of Retribution”

Høeg aligned with other contrarians, {like|